MW

Mark William Reilly

Director Director DIN 00981828
DIN 00981828 First appointment Oct 2003 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2003
Shareholding value Locked Premium profile

About Mark William Reilly

Data last updated:

Mark William Reilly has 22 years in corporate governance. Formerly with 1 company, such as Glaxosmithkline Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations.

DIN 00981828
Primary Designation Director
First Appointment 09 Oct 2003
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director09 Oct 20031924Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Glaxosmithkline Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Mark William Reilly

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mark William Reilly

Mark William Reilly has 22 years in corporate governance. Formerly with 1 company, such as Glaxosmithkline Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations.

Mark William Reilly is associated with 0 companies as a director.

Mark William Reilly has expertise in General Business.

Mark William Reilly has 22 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available